Medical News

RSS

Global food prices continue upward trend, but relatively stable cereal prices could prevent riots, FAO economist says

Global food prices rose in October and the U.N. Food and Agriculture Organization's (FAO) Food Price Index increased "for the fifth month in a row, the FAO said on Tuesday, Reuters reports.

4 Nov 2010

Acceleron receives grants for five projects under QTDP program

Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced it has been awarded grants for five projects under the Qualifying Therapeutic Discovery Project (QTDP) program.

4 Nov 2010

CorMedix awarded $488,959 QTDP program grant to develop Neutrolin and Deferiprone clinical programs

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, today announced it has been awarded two grants totaling $488,959 under the qualifying therapeutic discovery project ("QTDP") program established under Section 48D of the Internal Revenue Code. These grants were awarded based on applications CorMedix submitted for both its Neutrolin® and Deferiprone programs.

4 Nov 2010

Cempra to present information on solithromycin antimalarial agent at Atlanta Annual Meeting

Cempra Pharmaceuticals today announced abstracts to be presented on its novel fluoroketolide antibiotic, solithromycin (CEM-101), at the American Society of Tropical Medicine and Hygiene 59th Annual Meeting, November 3 to 7 in Atlanta. The abstracts will present new information on solithromycin's antimalarial activity. Additional data will demonstrate activity against Mycobacterium leprae.

4 Nov 2010

Cardium receives $245,000 grant under QTDP program

Cardium Therapeutics today announced that it was awarded a cash grant of approximately $245,000 under the U.S. Government's Qualifying Therapeutic Discovery Project program to further its Generx clinical development program.

4 Nov 2010

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine.

4 Nov 2010

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

Lithera, Inc. today announced positive results from a Phase IIb clinical study of LIPO-102, its novel injectable combination of salmeterol xinafoate (SX) and fluticasone propionate (FP) for selective, non-ablative fat reduction.

4 Nov 2010

pSivida awarded $489,000 grant under IRS Qualifying Therapeutic Discovery Project

pSivida Corp., a leader in the development of sustained release drug delivery products for the treatment of back-of-the-eye disease including the product candidate Iluvien™ for the treatment of Diabetic Macular Edema, today announced that it has been awarded two grants totaling $489,000 under the IRS Qualifying Therapeutic Discovery Project (QTDP). The grants were awarded to pSivida to help fund further research on new generations of the company's drug delivery technologies targeting ophthalmic diseases.

4 Nov 2010

Study links positive well-being to higher telomerase activity

Positive psychological changes that occur during meditation training are associated with greater telomerase activity, according to researchers at the University of California, Davis, and the University of California, San Francisco. The study is the first to link positive well-being to higher telomerase, an enzyme important for the long-term health of cells in the body.

4 Nov 2010

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.

4 Nov 2010

Cocrystal receives $733,438 in grants from QTDP program

Cocrystal Discovery, Inc., a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases, announced today that it has received $733,438 in grants from the Qualified Therapeutic Discovery Project (QTDP) administered under section 48D of the Internal Revenue Code.

4 Nov 2010

AAPC launches beta version of Health Plan Policy Search Tool

AAPC has launched the beta version of its Health Plan Policy Search Tool giving providers access to more than 500 local and national health plans. This online search tool retrieves provider manuals, policies, physician credentialing and Medicare/Medicaid eligibility through an easy to use online tool. Users can now quickly find vital information instead of spending hours searching for the same information on each health plans website.

4 Nov 2010

Florida to drop 350 uninsured HIV/AIDS patients from drug program; Ore. and Wash. set up enrollment periods for children's insurance; Calif. gets federal grant to update Medicaid program

The Miami Herald/The Sun Sentinel: "The Florida Department of Health plans to drop about 350 uninsured HIV/AIDS patients from a federally funded program that pays for all or most of their drugs, because of a budget crisis. An additional 2,000 or more HIV-positive patients are at risk of being bumped from the program unless the state can close a $16 million shortfall in the next few months, officials said Tuesday.

4 Nov 2010

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

Aduro BioTech announced today that it has been awarded two cash grants totaling approximately $442,000 under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.

4 Nov 2010

BioCurex files patent for synthetic peptide in RECAF test

BioCurex, Inc. today announced that it has filed a new patent within the Patent Cooperation Treaty, which presently includes 142 countries.

4 Nov 2010

Medicare reimbursement cuts lead to decline in unnecessary or inappropriate care

When Medicare policy changes led to reductions in reimbursement for hormonal treatment of prostate cancer, there was a sharp decline in its use among patients not likely to benefit from the treatment. But among patients for whom the therapy is clearly beneficial, doctors continued to prescribe it at the same rate, according to a new study.

4 Nov 2010

EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test

EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company's work in the development of their ColoMarker test, an early detection blood test for colon cancer.

4 Nov 2010

Omega third quarter net income decreases from $21.1 million to $17.0 million

Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended September 30, 2010.

4 Nov 2010

Aeolus receives $489,000 grant under QTDP program for two lead compounds

Aeolus Pharmaceuticals, Inc. today announced that it has been awarded a total of approximately $489,000 under the Qualifying Therapeutic Discovery Grant Program (QDTP) administered by the Internal Revenue Service and the Department of Health and Human Services.

4 Nov 2010

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

Bristol-Myers Squibb Company and Simcere Pharmaceutical Group, a leading pharmaceutical company in China, today announced an innovative strategic partnership to co-develop BMS-817378, a preclinical small molecule MET/VEGFR-2 inhibitor.

4 Nov 2010

Medical News

Global food prices continue upward trend, but relatively stable cereal prices could prevent riots, FAO economist says

Acceleron receives grants for five projects under QTDP program

CorMedix awarded $488,959 QTDP program grant to develop Neutrolin and Deferiprone clinical programs

Cempra to present information on solithromycin antimalarial agent at Atlanta Annual Meeting

Cardium receives $245,000 grant under QTDP program

New antibody with SGN-35 drug produces remission in Hodgkin lymphoma

Positive results from Lithera's LIPO-102 Phase IIb clinical study for abdominal fat reduction

pSivida awarded $489,000 grant under IRS Qualifying Therapeutic Discovery Project

Study links positive well-being to higher telomerase activity

Nymox awarded federal grant for NX-1207 Phase III BPH clinical trial program

Cocrystal receives $733,438 in grants from QTDP program

AAPC launches beta version of Health Plan Policy Search Tool

Florida to drop 350 uninsured HIV/AIDS patients from drug program; Ore. and Wash. set up enrollment periods for children's insurance; Calif. gets federal grant to update Medicaid program

Aduro receives $442,000 grant under QTDP program to support Listeria-based immunotherapy platform

BioCurex files patent for synthetic peptide in RECAF test

Medicare reimbursement cuts lead to decline in unnecessary or inappropriate care

EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test

Omega third quarter net income decreases from $21.1 million to $17.0 million

Aeolus receives $489,000 grant under QTDP program for two lead compounds

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News